EYPT icon

EyePoint (EYPT)

NASDAQ

$4.52

-$10.24 (

-69.39%

)

1D
5D
1M
6M
1Y
5Y
Pre market

EYPT: $4.52 / ₿ 0.0001 BTC / 7110 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$14.75
-
1.93
$4,569,885.62
$4.48 - $4.50
Yes

The EyePoint (EYPT) stock price has been falling

The EyePoint, Inc. Common Stock (EYPT) stock pre-market price today is $4.52, reflecting a -69.39% pre-market move since the market last closed. The company’s market capitalization stands at , with a daily trading volume of $4.57M shares. The previous closing price was $14.75.

USD icon
USD
EYPT icon
EYPT

Only available to USA clients through the Kraken app
or Kraken Pro.

How to buy EyePoint stock on Kraken

Follow these three simple steps to buy shares of EyePoint stock on Kraken. Create your Kraken account in moments and connect your preferred funding method to buy stocks including EYPT. Kraken offers an easy, secure and licensed way to get started.

Options trade light dark

Step 1: Sign up

Provide your email address and country of residence* to create an account and get started with our secure verification process.

Deposit funds

Step 2: Choose a payment method

Send a bank wire, make an ACH purchase, use a debit card or choose from several other payment methods.

Create an account

Step 3: Buy EyePoint

Select “Buy stocks” on either Kraken’s web or mobile app and search for your desired stock to start your purchase.

Why buy EyePoint stocks with Kraken?

Kraken offers a secure and intuitive to buy 11,000+ US listed stocks and ETF stocks in the US, as well as tokenized xStocks for certain regions outside of the US. Use Kraken’s flexible payment methods to buy EyePoint stocks with a debit card, bank transfer or other payment option.

Flexible funding options

Enjoy fast and flexible funding options

Transactions are instant

Buy and sell 11,000+ stocks, ETFs and commodities

Kraken level security

Keep your portfolio secure with Passkeys

What is EyePoint (EYPT)?

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Learn more before buying EyePoint stock

EYPT is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

EYPT is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

EYPT is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Yes. Kraken offers a secure, highly liquid and intuitive way to buy 11,000+ stocks, ETFs and commodities. With advanced trading tools built for both indvidual investors and professional institutions, Kraken offers an all-in-one way to invest in cryptocurrencies, stocks, ETFs and the most important assets for your financial future.

The first step for new invstors looking to buy stocks is to a secure, reputable and competitive stock trading platform such as Kraken. After opening and funding your account. From there, it can be helpful to first research EyePoint and its recent market performance, From there, Kraken makes it easy to buy fractional shares of EyePoint so you can start small and build your portfolio over time.

Yes. Kraken’s mobile app allows you to buy, sell, and manage EyePoint trades on the go from your smartphone.

Earnings reports, product launches, economic data, sector performance, and broad market conditions all influence the price movement of EyePoint stock.

No. Kraken makes it easy to buy fractional shares of EyePoint, meaning you do not need to purchase a full share in order to add EyePoint to your portfolio.

Explore 11,000+ stocks, ETF and commodities

Buy EyePoint and thousands of popular stocks, ETFs or commodities available on Kraken today (geo restrictions apply).

Most active

Explore the most-traded stocks today

SNYR icon
FAMI icon

FAMI

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

Want to learn more about equities?

Check out our Kraken Learn Center guides

General stock risks

Investing in stocks is risky and each stock can have its own set of risks. Below is a list of risks that generally apply to all stocks:

Volatility: The performance of stocks can be volatile, with their value dropping as quickly as it can rise. You should be prepared to lose all the money you invest in stocks.

Liquidity: Some stocks may suffer from low liquidity which could prevent you buying or selling them at the price you want or expect.

Complexity: Specific stocks and ETFs may carry with them specific complex risks that are hard to understand. Do your own research and if something sounds too good to be true, it probably is.

Don’t put all your eggs in one basket: Putting all your money into a single type of investment is risky. Spreading your money across different investments makes you less dependent on any one to do well.

If you want to learn more about specific risks related to equity securities, please visit our dedicated equities disclosure page.

Want to invest in EyePoint? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.